ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Medicamen Organics held its 31st AGM on September 25, 2026. Shareholders approved audited financial statements, director reappointment, secretarial auditor appointment, and related party transactions.
Medicamen Organics Ltd has scheduled its 31st Annual General Meeting for September 25, 2026. The board also approved the re-appointment of its Secretarial Auditors.
Medicamen Organics published a valuation report from M/s Jhamb & Associates on its website. The report supports shareholder approval for matters in the upcoming Extra-ordinary General Meeting.
Medicamen Organics Limited announced that all resolutions placed at its EGM on April 09, 2026, were passed with requisite majority. Key approvals include increasing authorized share capital, appointing an Executive Director, and preferential issuances of equity shares and convertible warrants to promoter and public categories. The results were confirmed by a Scrutinizer's Report.
Medicamen Organics Limited held an EGM on April 09, 2026, to approve several resolutions. Key items include increasing authorized share capital, appointing an Executive Director, and issuing 20,00,000 equity shares and 11,85,715 warrants on a preferential basis. Voting results will be disclosed separately.